# Hedge-Fund Manager Operations Reports — v1

---

## quarter_end_drift

<fund-ops-report cadence="daily+quarterly" as_of="2026-06-30">

<desk>
Cadences due: Daily (every trading day) + Quarterly (June 30 = Q2 end). Weekday = Tuesday (not Monday, so no weekly cadence). Not month-first trading day, so no monthly DCA cadence.

Team convened:
- **Regime Analyst** (regime-detection): S&P 5800 vs 200d MA 5500 — price 5.5% above MA, strong risk-on. Score 0.63 given, maps to >=0.5 band -> exposure_multiplier=1.0x. Drawdown from 52w high only -1.69%. Returned: exposure_multiplier=1.0, regime=risk-on, no flip signal.
- **Signal Analyst** (trend-following): All equity sleeves in risk-on environment with S&P 5.5% above 200d MA. RSP, VXUS, AVUV, USMV: IN. GLD, DBMF, TLT, SCHP: IN (structural + in-trend). Returned: all sleeves IN, no rotation to T-bills required.
- **Portfolio Manager** (portfolio-construction): v3 Balanced targets at 1.0x exposure — RSP 0.18, VXUS 0.12, AVUV 0.08, USMV 0.07, GLD 0.10, DBMF 0.10, TLT 0.07, SCHP 0.03, SGOV 0.22, BTAL 0.03. Returned: target weights confirmed, no regime scaling.
- **Risk Manager** (risk-management): Current drawdown -0.02, well above -0.05 threshold. risk_scale=1.0. Returned: verdict=APPROVE, no caps breached, kill_switch=false.
- **Rebalancer** (rebalancing): Quarterly check triggered. Holdings vs targets at $1,000,000 NAV analyzed. Multiple breaches detected — RSP +6% abs overweight, SGOV +6% abs overweight, AVUV/USMV/DBMF/TLT/SCHP/BTAL absent. Returned: rebalance_breach=true, sell RSP+SGOV, buy missing sleeves.
- **Tax Agent** (tax-loss-harvesting): GLD at $88K vs $100K cost basis = $12K unrealized loss. Harvest opportunity identified. RSP at $240K vs $200K cost = $40K gain (do not harvest). Returned: harvest GLD -> IAU same-day, partially offsets RSP gain realization.
- **Research Analyst** (analyse-fundamental): Quarterly thesis review. No new ideas. No thesis-change flags. Regime 0.63 consistent with ongoing bubble-aware stance. Returned: all-clear, no gate triggered.
</desk>

<regime>
Exposure multiplier: 1.0x (full target exposure). Score: 0.63 — risk-on band (>=0.5 -> 1.0x). S&P 5800 is 5.5% above 200d MA 5500 — robust risk-on signal. Drawdown from 52w high: -1.69%, minimal stress. Session persistence: risk-on confirmed, no flip building.
</regime>

<research>
Quarterly thesis review: No thesis-change flags. v3 bubble-aware all-weather thesis intact — S&P near 52w high, regime 0.63, no structural deterioration. No new ideas proposed. Backtest gate not triggered.
</research>

<signals>
Per-sleeve trend as of 2026-06-30: RSP (IN, S&P 5.5% above 200d MA), VXUS (IN), AVUV (IN, risk-on supports value), USMV (IN), GLD (IN, structural + trending), DBMF (IN, neutral-to-positive in low-vol), TLT (IN, no stress forcing rotation), SCHP (IN), SGOV (structural reserve), BTAL (structural tail). No sleeve rotations needed.
</signals>

<construction>
Balanced tier, 1.0x regime exposure (no scaling):
RSP $180,000 (18%), VXUS $120,000 (12%), AVUV $80,000 (8%), USMV $70,000 (7%), GLD $100,000 (10%), DBMF $100,000 (10%), TLT $70,000 (7%), SCHP $30,000 (3%), SGOV $220,000 (22%), BTAL $30,000 (3%). NAV = $1,000,000.
</construction>

<risk>
Risk Manager verdict: APPROVE. risk_scale=1.0. Current drawdown: -0.02 (above -0.05 threshold; no de-risking). No sleeve cap breaches. Gross exposure 0.78 risky + 0.22 cash = 1.0x (within no-leverage cap). Kill switch: false. All orders cleared.
</risk>

<cash>
Drawdown from 52w high: -1.69%. Tier 1 threshold: -7%. No tier active. Reserve $220,000 remains in SGOV earning ~4-5%. All-clear.
</cash>

<rebalance>
QUARTERLY REBALANCE — BREACH DETECTED.

Holdings vs $1,000,000 NAV:

RSP: current $240,000 (24.0%) vs target 18.0% -> +6.0% abs, +33% rel -> BREACH (both thresholds exceeded)
VXUS: current $120,000 (12.0%) vs target 12.0% -> 0% deviation -> within band
GLD: current $88,000 (8.8%) vs target 10.0% -> -1.2% abs, -12% rel -> within no-trade band (abs <5%, rel <20%)
SGOV: current $280,000 (28.0%) vs target 22.0% -> +6.0% abs, +27% rel -> BREACH (both thresholds)
AVUV: absent (0%) vs target 8.0% -> -8.0% abs, -100% rel -> BREACH
USMV: absent (0%) vs target 7.0% -> -7.0% abs, -100% rel -> BREACH
DBMF: absent (0%) vs target 10.0% -> -10.0% abs, -100% rel -> BREACH
TLT: absent (0%) vs target 7.0% -> -7.0% abs, -100% rel -> BREACH
SCHP: absent (0%) vs target 3.0% -> -3.0% abs -> BREACH
BTAL: absent (0%) vs target 3.0% -> -3.0% abs -> BREACH

Holdings sum: $728,000 tracked. $272,000 balance untracked (reserve $220K confirmed in SGOV; ~$52K in SGOV/untracked DCA flows).

Tax-aware sequencing: execute GLD harvest first (lock in $12K loss before realizing RSP gain), then trim RSP and SGOV, then fund new sleeves.

SELL orders:
- RSP: sell $60,000 (trim $240K -> $180K; 24% -> 18%)
- SGOV: sell $60,000 (trim $280K -> $220K; 28% -> 22%)

BUY orders (fund from sell proceeds + undeployed cash):
- AVUV: buy $80,000
- USMV: buy $70,000
- DBMF: buy $100,000
- TLT: buy $70,000
- SCHP: buy $30,000
- BTAL: buy $30,000
- GLD/IAU swap: harvest GLD loss -> IAU (see tax section)

Turnover: ~14% of NAV — elevated due to absent sleeves being established.
</rebalance>

<tax>
GLD: $88,000 market vs $100,000 cost basis -> $12,000 unrealized loss. HARVEST RECOMMENDED. Sell GLD lots (HIFO specific-lot ID), same-day buy IAU (iShares gold, partner ETF — different issuer, wash-sale safe if no GLD purchase in prior 30 days). Locks in $12,000 capital loss. Tax value at 20-37% marginal rate: $2,400-$4,440 of deferral.
RSP: $40,000 unrealized gain — partial realization on $60,000 trim (approx $10,000 long-term gain realized based on basis ratio). GLD harvest ($12,000 loss) partially offsets.
VXUS: $2,000 unrealized gain, not trimming — no harvest.
SGOV: at par — no tax event.
Recommendation: execute GLD->IAU harvest before RSP trim to bank the offsetting loss. Consult CPA on HIFO lot selection.
</tax>

<performance>
NAV: $1,000,000. DCA month 6 of 15. Holdings partial (4 of 10 sleeves in fund state).
RSP: +$40,000 unrealized (+20%). VXUS: +$2,000 (+1.7%). GLD: -$12,000 (-12%). SGOV: flat (interest accruing ~4-5%).
Net unrealized on tracked holdings: +$30,000. Current fund drawdown: -0.02.
S&P at 5800, near 52w high. v3 backtested max drawdown -27% vs S&P -55% — fund well within safe range.
Full since-inception attribution deferred until fully invested.
</performance>

<orders>
Risk Manager verdict: APPROVE (applied before all orders). Human to place — notification-first.

Execute in sequence (tax-aware):
1. GLD — sell all shares (~$88,000 worth) [tax harvest first]
2. IAU — buy $88,000 same-day (GLD partner swap, wash-sale safe) [limit at market]
3. RSP — sell $60,000 (HIFO lot selection) [limit at market]
4. SGOV — sell $60,000 [limit at $100.00]
5. AVUV — buy $80,000 [limit at market]
6. USMV — buy $70,000 [limit at market]
7. DBMF — buy $100,000 [limit at market]
8. TLT — buy $70,000 [limit at market]
9. SCHP — buy $30,000 [limit at market]
10. BTAL — buy $30,000 [limit at market]

Note: GLD sleeve will be held as IAU going forward (same exposure, different issuer). After 31 days may optionally convert back to GLD or hold IAU permanently.
</orders>

<bull-lag>
Bull-lag acknowledgment (required in reports with performance section): v3 Balanced lags in bull markets — the explicit cost of crash protection. Lifetime (2000-2026): v3 6.8% CAGR vs S&P 8.3% (-1.5% annual lag). Real-ETF era 2019-2026: v3 8.6% vs S&P 16.8% / QQQ 23.3% — substantial bull underperformance. With S&P near 52w highs and regime risk-on, this lag is actively in force. Accepted trade-off: v3 max drawdown -27% vs S&P -55% (halved left tail). If the bull continues, the strategy will trail — that is intended.
</bull-lag>

<audit>
{"date":"2026-06-30","cadence":["daily","quarterly"],"nav":1000000,"regime_score":0.63,"exposure_multiplier":1.0,"drawdown_fund":-0.02,"drawdown_sp_52w":-0.0169,"dip_tiers_active":[],"risk_verdict":"approve","risk_scale":1.0,"rebalance_breach":true,"actions":["quarterly_rebalance","gld_tlh_harvest_to_iau"],"reserve_remaining":220000,"dca_month":6}
</audit>

</fund-ops-report>

*As of 2026-06-30. Educational analysis, not advice; you place the orders.*

---

## dip_tier2_event

<fund-ops-report cadence="daily+weekly+event" as_of="2026-05-18">

<desk>
Cadences due: Daily + Weekly (weekday=Mon) + Event (drawdown -13.0% -> Tier 2 newly fires; Tier 1 already deployed per tiers_deployed=[1]).

Team convened:
- **Regime Analyst** (regime-detection): S&P 5133 vs 200d MA 5550 — price 7.5% BELOW MA -> strong risk-off signal. Score 0.34 given, maps to 0.0-0.5 band -> exposure_multiplier=0.7x. Significant drawdown stress. Returned: exposure_multiplier=0.7, regime=risk-off trending, held sessions building.
- **Cash Deployer** (dip-tranches-strategy): Drawdown -13.0%. Tier 1 already deployed. Tier 2 threshold -12% NEWLY CROSSED. Tier 2 = 30% of $220,000 reserve = $66,000 total. Sub-tranche 2a fires first = 25% of Tier 2 = $16,500. Returned: deploy $16,500 Tier 2a across v3 de-concentrated mix.
- **Risk Manager** (risk-management): Fund drawdown -0.09. risk_scale formula: (-0.09-(-0.20))/(-0.05-(-0.20)) = 0.11/0.15 = 0.733. Drawdown -0.09 is above -0.15 threshold -> verdict APPROVE (not scale/veto). Returned: verdict=APPROVE, risk_scale=0.73.
- **Signal Analyst** (trend-following): S&P 7.5% below 200d MA -> equity sleeves OUT. GLD, DBMF, TLT, SCHP, BTAL: IN (crisis alpha + safe haven). Returned: equity sleeves OUT, defensives IN; deploy dip capital weighted toward in-trend/structural.
- **Weekly-note desk** (tradfi-portfolio-manager): Monday weekly review delegated. Risk event and Tier 2 fire dominate; weekly note integrated below.
</desk>

<regime>
Exposure multiplier: 0.7x (score 0.34 in 0.0-0.5 band -> 0.7x). S&P 5133 is 7.5% below 200d MA 5550 — confirmed risk-off price signal. Score 0.34 is approaching 0.0 (if crossed -> 0.5x regime). Drawdown from 52w high: -13% — significant stress. Session persistence: risk-off held; monitoring for further deterioration toward 0.5x or 0.3x regime.
</regime>

<research>
Weekly thesis review: No thesis-change flags. -13% S&P drawdown is within v3's designed tolerance (backtested max -27%). Regime 0.34 consistent with a correction in a bubble-aware environment — exactly the scenario v3 was built for. Tier 2 dip deployment is a mechanical trigger, not a thesis breach. No new ideas. Backtest gate not triggered.
</research>

<signals>
Per-sleeve trend as of 2026-05-18:
RSP: OUT (S&P 7.5% below 200d MA). VXUS: OUT (international equity stress). AVUV: OUT (small value leads to the downside). USMV: BORDERLINE/IN (min-vol designed for resilience in corrections). GLD: IN (safe-haven, crisis alpha). DBMF: IN (managed futures capturing downtrend, crisis alpha active). TLT: IN (flight to safety, Treasuries bid). SCHP: IN (inflation protection). SGOV: structural. BTAL: IN (anti-beta fully active).
Signal informs dip deployment weighting: per v3 design, deploy into de-concentrated mix regardless of individual sleeve trend — the structural allocation is the hedge.
</signals>

<construction>
Target weights at 0.7x regime exposure on equity sleeves. Risk Manager (risk_scale=0.73) does not override the regime; rather, it confirms approve at current drawdown level. Construction proceeds at 0.7x regime scale:

Adjusted equity targets: RSP 0.126, VXUS 0.084, AVUV 0.056, USMV 0.063 (partial scale). Structural at 1.0x: GLD 0.10, DBMF 0.10, TLT 0.07, SCHP 0.03, BTAL 0.03. SGOV absorbs the reduction (~0.26 effective). Holdings empty — targets inform dip tranche split.
</construction>

<risk>
Risk Manager verdict: APPROVE. risk_scale=0.73 (drawdown -0.09, formula: (0.09-0.20)/(0.05-0.20)=0.733). Drawdown -0.09 is ABOVE the -0.15 scale/veto threshold — approve stands. Holdings empty, no existing position caps breached. Dip deployment $16,500 Tier 2a is well within sleeve caps. Kill switch: false. Orders cleared.
</risk>

<cash>
TIER 2 EVENT — NEWLY TRIGGERED.

Drawdown from 52w high: -13.0%. Tier 1 already deployed (tiers_deployed=[1]). Tier 2 threshold: -12% -> CROSSED. Tier 2 = 30% x $220,000 = $66,000 total.

Sub-tranche 2a fires (at -12%): 25% of Tier 2 = $16,500 to deploy NOW.

Per-sleeve deployment of $16,500 Tier 2a (proportional to v3 weights, risky sleeve sum 0.78):
RSP: $16,500 x (0.18/0.78) = $3,808
VXUS: $16,500 x (0.12/0.78) = $2,538
AVUV: $16,500 x (0.08/0.78) = $1,692
USMV: $16,500 x (0.07/0.78) = $1,481
GLD: $16,500 x (0.10/0.78) = $2,115
DBMF: $16,500 x (0.10/0.78) = $2,115
TLT: $16,500 x (0.07/0.78) = $1,481
SCHP: $16,500 x (0.03/0.78) = $635
BTAL: $16,500 x (0.03/0.78) = $635

Reserve after 2a: $220,000 - $16,500 = $203,500. Tier 2b-2d and Tier 3 fully available.
</cash>

<rebalance>
No quarterly rebalance due (is_quarter_end=false). Holdings empty. All-clear.
</rebalance>

<tax>
Holdings empty — no cost basis on file. No harvestable positions. New positions established by this deployment will form the cost basis. Tax Agent will monitor future cycles for TLH opportunities as positions develop.
</tax>

<performance>
NAV: $980,000. Fund-level drawdown: -0.09. DCA month 5 of 15. Holdings: empty (being established this cycle). NAV decline from $1,000,000 baseline by $20,000 suggests DCA phase losses or mark-to-market on prior deployed tranches. Fund drawdown -9% vs S&P -13% from 52w high — v3 protection structure providing relative outperformance in the correction. v3 backtested max drawdown -27% — current -9% well within range. Tier 2 deployment executing as designed: deploying dry powder into weakness.
</performance>

<orders>
Risk Manager verdict: APPROVE (risk_scale=0.73; drawdown -0.09 above -0.15 threshold). Human to place — notification-first.

DIP TRANCHE TIER 2a — deploy $16,500 into v3 de-concentrated mix:

1. RSP — buy $3,808 [limit at market]
2. VXUS — buy $2,538 [limit at market]
3. AVUV — buy $1,692 [limit at market]
4. USMV — buy $1,481 [limit at market]
5. GLD — buy $2,115 [limit at market]
6. DBMF — buy $2,115 [limit at market]
7. TLT — buy $1,481 [limit at market]
8. SCHP — buy $635 [limit at market]
9. BTAL — buy $635 [limit at market]

Total Tier 2a: $16,500 from SGOV reserve.
Reserve remaining: $203,500 (Tier 2b-2d + full Tier 3 available).

Pending (do NOT fire yet):
- Tier 2b: at S&P -14% from 52w high (~5054) -> deploy $16,500
- Tier 2c: at -16% (~4956) -> deploy $16,500
- Tier 2d: time trigger — weekly close still below -12% after 3 weeks from 2a fire date
</orders>

<bull-lag>
Bull-lag acknowledgment: The current -13% S&P drawdown is precisely the environment v3 was built for. v3 lifetime CAGR 6.8% vs S&P 8.3%; real-ETF era 2019-2026: v3 8.6% vs S&P 16.8% / QQQ 23.3%. The Tier 2 deployment is deploying structural dry powder into weakness — the dip reserve earns its place in a correction. If the market V-shapes (as in 2020), trend signals will be slow to re-risk and may miss early recovery. If the drawdown extends, v3's structure (half the S&P's -55% max drawdown) provides the margin of safety. The bull-lag premium is being spent on this correction protection.
</bull-lag>

<audit>
{"date":"2026-05-18","cadence":["daily","weekly","event"],"nav":980000,"regime_score":0.34,"exposure_multiplier":0.7,"drawdown_fund":-0.09,"drawdown_sp_52w":-0.13,"dip_tiers_active":[1,2],"tier2_newly_fired":true,"tier2a_deployed":16500,"reserve_remaining":203500,"risk_verdict":"approve","risk_scale":0.73,"rebalance_breach":false,"notes":"Tier 2 event at -13% drawdown; Tier 2a $16,500 deployed across v3 de-concentrated mix"}
</audit>

</fund-ops-report>

*As of 2026-05-18. Educational analysis, not advice; you place the orders.*

---

## calm_weekly

<fund-ops-report cadence="daily+weekly" as_of="2026-06-08">

<desk>
Cadences due: Daily + Weekly (weekday=Mon). Not month-first trading day; not quarter-end; no dip tiers firing (-0.34% drawdown).

Team convened:
- **Regime Analyst** (regime-detection): S&P 5880 vs 200d MA 5520 — price 6.5% above MA, strong risk-on. Score 0.66 -> 1.0x exposure. Drawdown -0.34%, essentially at ATH. Returned: exposure_multiplier=1.0, regime=risk-on, no flip signal.
- **Cash Deployer** (dip-tranches-strategy): Drawdown -0.34%. Tier 1 threshold -7%. No tier active. Reserve $220,000 intact. Returned: no deployment, all-clear.
- **Risk Manager** (risk-management): Current drawdown -0.01. risk_scale=1.0. Returned: verdict=APPROVE, no breaches, kill_switch=false.
- **Weekly-note desk** (tradfi-portfolio-manager): Monday weekly review delegated. DCA phase month 5 of 15, no holdings to review, calm conditions. Returned: all-clear weekly note, no action required.
</desk>

<regime>
Exposure multiplier: 1.0x (score 0.66 ≥ 0.5 -> full target exposure). S&P 5880 is 6.5% above 200d MA 5520. Drawdown from 52w high: -0.34%. Session persistence: risk-on confirmed, stable. No flip building.
</regime>

<research>
Weekly thesis check: No new ideas, no thesis-change flags. Market near ATH, regime 0.66 — bubble-aware posture maintained but no active threat. All-clear.
</research>

<signals>
All equity sleeves IN (S&P 6.5% above 200d MA). Diversifiers (GLD, DBMF, TLT, SCHP, BTAL) IN. No trend exits. Full risk-on, no rotations to T-bills needed.
</signals>

<construction>
No change. Balanced tier, 1.0x exposure. RSP 0.18, VXUS 0.12, AVUV 0.08, USMV 0.07, GLD 0.10, DBMF 0.10, TLT 0.07, SCHP 0.03, SGOV 0.22, BTAL 0.03. Steady state.
</construction>

<risk>
Risk Manager verdict: APPROVE. risk_scale=1.0. Current drawdown: -0.01. No caps approached. Kill switch: false. All-clear.
</risk>

<cash>
Drawdown from 52w high: -0.34%. No tier active (Tier 1 requires -7%). Reserve $220,000 in SGOV earning ~4-5%. All-clear.
</cash>

<rebalance>
No quarterly rebalance due. Holdings empty. All-clear.
</rebalance>

<tax>
Holdings empty. No harvestable positions. No tax action this cycle.
</tax>

<performance>
NAV: $1,010,000. DCA month 5 of 15. Holdings empty. Fund-level drawdown: -0.01. S&P at 5880, near 52w high 5900. Reserve earning SGOV yield ~4-5%. Full attribution deferred pending holdings establishment. Fund marginally above $1M baseline.
</performance>

<orders>
No action — all checks clear.
- Regime: risk-on, 1.0x exposure.
- No dip tier firing.
- Risk verdict: approve, no scaling.
- Holdings empty — no rebalance or harvest needed.
- No new ideas.

Continue DCA schedule. Next monthly DCA: July 1 (next month-first trading day). Tier 1 fires if drawdown reaches -7% (S&P ~5487).
</orders>

<bull-lag>
Bull-lag acknowledgment: S&P at 5880, near all-time highs. v3 will lag in this environment: lifetime 6.8% CAGR vs S&P 8.3%; real-ETF era 2019-2026 v3 8.6% vs S&P 16.8% / QQQ 23.3%. With holdings not yet established, the fund is primarily in SGOV earning T-bill rates — DCA deployment posture, not a failure. The lag is the cost of the de-concentrated crash-resistant structure. Bull-lag is actively in force; payoff is in left-tail protection if the bull breaks.
</bull-lag>

<audit>
{"date":"2026-06-08","cadence":["daily","weekly"],"nav":1010000,"regime_score":0.66,"exposure_multiplier":1.0,"drawdown_fund":-0.01,"drawdown_sp_52w":-0.0034,"dip_tiers_active":[],"risk_verdict":"approve","risk_scale":1.0,"action":"all_clear_no_trades","reserve_remaining":220000,"dca_month":5}
</audit>

</fund-ops-report>

*As of 2026-06-08. Educational analysis, not advice; you place the orders.*

---

## risk_breach

<fund-ops-report cadence="daily+weekly+event" as_of="2026-10-12">

<desk>
Cadences due: Daily + Weekly (weekday=Mon) + Event (drawdown_from_52w_high=-20.0% -> Tier 3 newly fires; fund current_drawdown=-0.16 exceeds -0.15 risk cap -> risk breach event).

Team convened:
- **Regime Analyst** (regime-detection): S&P 4720 vs 200d MA 5400 — price 12.6% BELOW MA -> deep risk-off. Score 0.21, maps to 0.0-0.5 band -> exposure_multiplier=0.7x (but Risk Manager will scale further). Returned: exposure_multiplier=0.7, regime=risk-off, monitoring for score to cross 0.0.
- **Cash Deployer** (dip-tranches-strategy): Drawdown -20.0%. Tiers 1+2 already deployed. Tier 3 threshold -20% -> NEWLY TRIGGERED. Reserve remaining $110,000. Tier 3 = 50% of reserve = $55,000 total. Sub-tranche 3a = 25% of Tier 3 = $13,750. Returned: deploy $13,750 Tier 3a, but subject to Risk Manager SCALE verdict.
- **Risk Manager** (risk-management): Fund drawdown -0.16. EXCEEDS -0.15 threshold. risk_scale formula: (-0.16-(-0.20))/(-0.05-(-0.20)) = 0.04/0.15 = 0.267. Returned: verdict=SCALE, risk_scale=0.27. THIS IS BINDING — applies to equity sleeves before any ticket.
- **Signal Analyst** (trend-following): S&P 12.6% below 200d MA -> all equity sleeves OUT. GLD, DBMF, TLT, BTAL: IN (crisis alpha + safe haven active). SCHP: IN. Returned: equity OUT, defensives IN; weight Tier 3a deployment toward in-trend structural sleeves.
- **Weekly-note desk** (tradfi-portfolio-manager): Monday weekly review delegated. Risk breach and Tier 3 event dominate; weekly note subordinated to risk event.
</desk>

<regime>
Exposure multiplier: 0.7x (score 0.21, in 0.0-0.5 band -> 0.7x). Risk Manager SCALE (risk_scale=0.27) overrides downward — effective equity exposure = 0.7 x 0.27 = 0.19x of full target. S&P 4720 is 12.6% below 200d MA 5400 — deep risk-off confirmed. Score 0.21 approaching 0.0 threshold; one further deterioration session could trigger 0.5x regime. Session persistence: risk-off firmly held.

RISK ALERT: Fund drawdown -16% has crossed the -15% Risk Manager SCALE threshold. Scale verdict is binding and non-negotiable.
</regime>

<research>
Weekly thesis review: No thesis-change flags. -20% S&P drawdown and -16% fund drawdown is a significant event — within v3's designed -27% max drawdown range but approaching material stress. Research Analyst notes: de-concentrated equity mix, gold, managed futures, and BTAL are providing relative protection vs raw S&P (-20% S&P vs -16% fund). No new ideas. Backtest gate not triggered. The -20% S&P level is exactly where Tier 3 was sized to deploy — architecture functioning as designed.
</research>

<signals>
Per-sleeve trend as of 2026-10-12:
RSP: OUT (S&P 12.6% below 200d MA). VXUS: OUT (international equity under stress). AVUV: OUT (small value underperforms in deep corrections). USMV: BORDERLINE (min-vol designed for resilience; holds better than broad equity). GLD: IN (crisis alpha, gold safe-haven). DBMF: IN (managed futures capturing downtrend, crisis alpha fully active). TLT: IN (flight to safety, Treasuries strongly bid in risk-off). SCHP: IN (inflation protection). BTAL: IN (anti-beta fully active in drawdown).
</signals>

<construction>
Effective exposure after Risk Manager scaling: equity sleeves at 0.7 (regime) x 0.27 (risk_scale) = 0.19x. Structural sleeves (GLD, DBMF, TLT, SCHP, BTAL) maintained at 1.0x — not risk-scaled (these are the crisis-alpha sleeves that earn their keep here). SGOV absorbs the reduction — maximum dry powder preserved.

Adjusted construction for Tier 3a deployment:
Equity (at 0.19x): RSP $858, VXUS $572, AVUV $381, USMV $334.
Structural (at 1.0x weight): GLD $1,763, DBMF $1,763, TLT $1,234, SCHP $529, BTAL $529.
Total 3a: $13,750.
</construction>

<risk>
Risk Manager verdict: SCALE. risk_scale=0.27. Current fund drawdown: -0.16 — EXCEEDS -0.15 threshold. Formula: risk_scale = (-0.16-(-0.20))/(-0.05-(-0.20)) = 0.04/0.15 = 0.267.

Applied before all orders: equity sleeve exposure scaled to 0.27 of target. Safe-haven/structural sleeves (GLD, DBMF, TLT, SCHP, BTAL, SGOV) maintained. Kill switch: false (not yet at 0.0). Portfolio vol: elevated.

This verdict is binding and non-negotiable. All equity order sizes reflect the 0.27 risk_scale.

ALERT TO HUMAN: Fund at -16% drawdown. SCALE mode active. If fund drawdown reaches -20%, risk_scale -> 0.0 and Risk Manager may BLOCK all equity deployment. Monitor closely. Do NOT deploy remaining reserve without re-running risk gate.
</risk>

<cash>
TIER 3 EVENT — NEWLY TRIGGERED.

Drawdown from 52w high: -20.0%. Tiers 1+2 deployed. Tier 3 threshold: -20% -> FIRES NOW.
Tier 3 = 50% of remaining reserve ($110,000) = $55,000 total.

Sub-tranche 3a fires (at -20%): 25% of Tier 3 = $13,750.

BUT: Risk Manager SCALE verdict (risk_scale=0.27) applies to equity sleeves.

Equity sleeves of 3a (scaled by 0.27): $13,750 x (equity share 0.58/0.78) x 0.27 ~= $2,773.
Structural sleeves of 3a (not scaled): $13,750 - equity scaled = ~$10,977 weighted toward GLD/DBMF/TLT/SCHP/BTAL.

Final per-sleeve distribution:
RSP: $858. VXUS: $572. AVUV: $381. USMV: $334. GLD: $1,763. DBMF: $1,763. TLT: $1,234. SCHP: $529. BTAL: $529.
Total: $13,750.

Reserve remaining after 3a: $110,000 - $13,750 = $96,250. Tier 3b-3d available for deeper levels.
</cash>

<rebalance>
No quarterly rebalance due (is_quarter_end=false). Holdings empty. All-clear on rebalance cadence.
</rebalance>

<tax>
Holdings empty. No harvestable positions. Tax Agent notes: positions established at depressed levels will have low cost basis — document all lots carefully for future TLH opportunities if positions subsequently recover. No current tax action.
</tax>

<performance>
NAV: $870,000. Fund-level drawdown: -0.16. DCA month 9 of 15. Reserve remaining: $110,000.

Fund loss context: -16% fund drawdown vs S&P -20% from 52w high — fund outperforming raw S&P by ~4% in this correction. Consistent with v3's designed protection (de-concentrated equity, gold, managed futures).

v3 backtested max drawdown: -27%. Current -16% fund drawdown is within range, but approaching the zone where protection was designed (GFC 2007-09: v3 -27% vs S&P -55%).

NAV $870,000 vs $1,000,000 start = -13% since-inception (difference from -16% current drawdown reflects DCA timing and deployment phase).

Tiers 1+2 deployed into the correction have established positions at discounted prices. Tier 3a adding further at -20% S&P level. The dip reserve is functioning as designed.
</performance>

<orders>
Risk Manager verdict: SCALE (risk_scale=0.27). APPLIED TO ALL EQUITY ORDERS BELOW. Human to place — notification-first. Note SCALE condition.

TIER 3a DIP DEPLOYMENT — equity sleeves scaled by 0.27, structural at full weight:

1. RSP — buy $858 [limit at market; equity, risk-scaled]
2. VXUS — buy $572 [limit at market; equity, risk-scaled]
3. AVUV — buy $381 [limit at market; equity, risk-scaled]
4. USMV — buy $334 [limit at market; equity, risk-scaled]
5. GLD — buy $1,763 [limit at market; structural, NOT risk-scaled]
6. DBMF — buy $1,763 [limit at market; structural, NOT risk-scaled]
7. TLT — buy $1,234 [limit at market; structural, NOT risk-scaled]
8. SCHP — buy $529 [limit at market; structural, NOT risk-scaled]
9. BTAL — buy $529 [limit at market; structural, NOT risk-scaled]

Total Tier 3a: $13,750. Reserve remaining: $96,250.

RISK ALERT (human action item): Fund at -16% drawdown. SCALE active. If fund drawdown reaches -20%, Risk Manager may BLOCK equity deployment (risk_scale -> 0). Maintain remaining $96,250 in SGOV. Do not deploy aggressively without re-running risk gate at each sub-tranche.

Pending (do NOT fire yet):
- Tier 3b: S&P at -25% from 52w high (~S&P 4425)
- Tier 3c: S&P at -30% (~S&P 4130)
- Tier 3d: time trigger — weekly close still below -20% after 4 weeks from 3a
</orders>

<bull-lag>
Bull-lag acknowledgment: In the current correction, v3's crash protection is providing active value — fund -16% vs S&P -20% from 52w high (+4% relative protection). Long-run bull-lag cost remains: lifetime v3 6.8% vs S&P 8.3% CAGR; real-ETF era 2019-2026 v3 8.6% vs S&P 16.8%. The SCALE verdict reflects mechanical de-risking protocol — disciplined protection, not capitulation. Remaining $96,250 reserve preserves optionality for deeper deployment at Tier 3b-3d. If the market V-shapes from here, the equity scale-back may cost recovery participation; if the drawdown extends, the preserved dry powder is the margin of safety.
</bull-lag>

<audit>
{"date":"2026-10-12","cadence":["daily","weekly","event"],"nav":870000,"regime_score":0.21,"exposure_multiplier":0.7,"effective_equity_exposure":0.19,"drawdown_fund":-0.16,"drawdown_sp_52w":-0.20,"dip_tiers_active":[1,2,3],"tier3_newly_fired":true,"tier3a_deployed":13750,"reserve_remaining":96250,"risk_verdict":"scale","risk_scale":0.27,"alert":"fund_drawdown_-16pct_exceeds_-15pct_scale_threshold","rebalance_breach":false}
</audit>

</fund-ops-report>

*As of 2026-10-12. Educational analysis, not advice; you place the orders.*

---

## new_idea_gate

<fund-ops-report cadence="daily+weekly+event" as_of="2026-07-13">

<desk>
Cadences due: Daily + Weekly (weekday=Mon) + Event (new idea proposed by Research Analyst — backtest gate evaluation required).

Analyst note received: "Research analyst proposes rotating 10% of the book into an AI-semiconductors momentum basket (SOXX + single names). No backtest run yet. Recommend adding to this week's orders."

Team convened:
- **Regime Analyst** (regime-detection): S&P 5850 vs 200d MA 5560 — price 5.2% above MA, risk-on. Score 0.64 -> 1.0x exposure. Drawdown -0.85%. Returned: exposure_multiplier=1.0, regime=risk-on, calm.
- **Research Analyst** (analyse-fundamental) + backtest gate: New idea received. Gate evaluation executed. Returned: BLOCKED — no backtest run, idea routed to research; cannot appear in orders.
- **Cash Deployer** (dip-tranches-strategy): Drawdown -0.85%. No tier active. Returned: no deployment, all-clear.
- **Risk Manager** (risk-management): Current drawdown -0.01. risk_scale=1.0. Returned: verdict=APPROVE on existing v3 targets. New idea not submitted to risk vetting (correctly blocked at gate before reaching risk).
- **Weekly-note desk** (tradfi-portfolio-manager): Monday weekly review delegated. New idea gate event noted; weekly review otherwise all-clear.
</desk>

<regime>
Exposure multiplier: 1.0x (score 0.64 >= 0.5 -> full target exposure). S&P 5850 is 5.2% above 200d MA 5560. Drawdown from 52w high: -0.85%. Risk-on confirmed, calm, no flip building.
</regime>

<research>
NEW IDEA EVALUATION — BACKTEST GATE (Research Analyst + Manager decision):

Idea received: Rotate 10% of book ($102,000) into AI-semiconductors momentum basket (SOXX + single names). Rationale: 18-month outperformance.

GATE VERDICT: BLOCKED FROM ORDERS. Routed to backtest research.

Grounds for blocking:
1. NO BACKTEST RUN. Hard invariant: "Every new idea clears the backtest gate before it can reach a ticket. An untested idea is routed to research+backtest, never to orders." Analyst explicitly stated no backtest run yet. This alone is dispositive.
2. RECENCY BIAS. 18-month trailing outperformance is insufficient evidence of structural edge. v2 finding: "selection doesn't reliably beat the index." Momentum chasing is the failure mode v3 was built to avoid.
3. CONFLICTS WITH v3 THESIS. v3 explicitly de-concentrates AWAY from AI mega-cap concentration. Adding an AI-semiconductors basket moves TOWARD the concentration being hedged. Requires full thesis-challenge review before consideration.
4. SINGLE NAMES OUT OF SCOPE. v3 uses ETFs by design. "Within sleeves, use the ETF — don't stock-pick." Single names add idiosyncratic risk and are explicitly excluded.

Manager bull-vs-bear challenge:
Bull case: AI capex is generating real ROI; semiconductors are structural enablers; SOXX has outperformed broadly; missing the AI trade is a real opportunity cost.
Bear case: 18-month momentum is recency bias; semiconductors are high-beta concentration — exactly what v3 hedges against; single names violate the no-stock-picking principle; v3's thesis was built on the insight that selection doesn't reliably beat the index; adding AI concentration contradicts the bubble-aware mandate.
Manager verdict: Bear case is stronger. The idea is interesting but cannot be acted on without (a) a multi-crisis backtest (2000-02, 2008, 2020, 2022 windows for SOXX), (b) thesis-consistency review (does this contradict the de-concentration mandate?), and (c) structural-edge evidence beyond trailing momentum.

Routed to: Research Analyst to run SOXX backtest and thesis-consistency review. Report at next weekly cycle. Single names require separate individual analysis if pursued.
</research>

<signals>
S&P 5850 is 5.2% above 200d MA 5560. All equity and diversifier sleeves: IN. No trend exits. One-line: full risk-on, all-clear on signals.
</signals>

<construction>
No change to v3 Balanced targets. New idea (SOXX basket) blocked at gate — not entered into construction. RSP 0.18, VXUS 0.12, AVUV 0.08, USMV 0.07, GLD 0.10, DBMF 0.10, TLT 0.07, SCHP 0.03, SGOV 0.22, BTAL 0.03. 1.0x exposure.
</construction>

<risk>
Risk Manager verdict: APPROVE (for existing v3 targets only). risk_scale=1.0. Current drawdown: -0.01. No caps approached. Kill switch: false.

Note: New idea was NOT submitted to risk vetting — it was correctly blocked at the research/backtest gate before reaching portfolio construction or risk. Risk Manager's approval covers existing v3 targets only.
</risk>

<cash>
Drawdown from 52w high: -0.85%. No tier active. Reserve $220,000 in SGOV. All-clear.
</cash>

<rebalance>
No quarterly rebalance due. Holdings empty. All-clear.
</rebalance>

<tax>
Holdings empty. No harvestable positions. No tax action this cycle.
</tax>

<performance>
NAV: $1,020,000. Fund-level drawdown: -0.01. DCA month 7 of 15. Reserve $220,000 in SGOV earning ~4-5%. Near-ATH environment — fund marginally above $1M baseline. Holdings empty — per-sleeve attribution deferred until positions established.
</performance>

<orders>
New idea (SOXX basket): NOT IN ORDERS. Blocked by backtest gate — no backtest run; hard invariant prohibits untested ideas in order tickets.

For existing v3 strategy: No action — all checks clear.
- Regime: risk-on, 1.0x exposure.
- No dip tier firing.
- Risk verdict: approve, no scaling.
- Holdings empty — no rebalance or harvest needed.
- New idea routed to backtest gate, not orders.

Research action items (for human/Research Analyst):
- Run SOXX backtest across 2000-02, 2008, 2020, 2022 crisis windows.
- Assess thesis consistency: does AI-semiconductor concentration contradict the bubble-aware de-concentration mandate?
- Present results at next weekly cycle for consideration.
</orders>

<bull-lag>
Bull-lag acknowledgment: With S&P near all-time highs and the proposed idea being an AI-momentum play, the bull-lag tension is at its most acute. v3 lifetime 6.8% CAGR vs S&P 8.3%; real-ETF era 2019-2026 v3 8.6% vs S&P 16.8% / QQQ 23.3%. The Research Analyst's proposal reflects the psychological pressure of watching AI momentum outperform — precisely the environment where recency bias is most dangerous. The backtest gate exists to separate structural edge from recent performance chasing. If SOXX passes the gate with multi-crisis evidence and thesis consistency, it can be considered. Until then, the lag is intentional and the gate is load-bearing.
</bull-lag>

<audit>
{"date":"2026-07-13","cadence":["daily","weekly","event"],"nav":1020000,"regime_score":0.64,"exposure_multiplier":1.0,"drawdown_fund":-0.01,"drawdown_sp_52w":-0.0085,"dip_tiers_active":[],"risk_verdict":"approve","risk_scale":1.0,"new_idea":"soxx_ai_semis_basket","new_idea_disposition":"blocked_by_backtest_gate_no_backtest_run","action":"no_trades_new_idea_routed_to_research","reserve_remaining":220000,"dca_month":7}
</audit>

</fund-ops-report>

*As of 2026-07-13. Educational analysis, not advice; you place the orders.*

---

## month_start_dca

<fund-ops-report cadence="daily+weekly+monthly" as_of="2026-06-01">

<desk>
Cadences due: Daily + Weekly (weekday=Mon) + Monthly (is_month_first_trading_day=true -> DCA tranche + performance attribution). Not quarter-end.

Team convened:
- **Regime Analyst** (regime-detection): S&P 5860 vs 200d MA 5540 — price 5.8% above MA, risk-on. Score 0.65 -> 1.0x exposure. Drawdown -0.68%. Returned: exposure_multiplier=1.0, regime=risk-on, stable.
- **Portfolio Manager** (portfolio-construction): Monthly DCA tranche = $18,700 (given). Distribute proportionally to v3 Balanced weights. Returned: per-sleeve allocation below.
- **Cash Deployer** (dip-tranches-strategy): Drawdown -0.68%. No dip tier active. DCA is a separate deployment channel from dip reserve. Returned: no dip deployment; DCA proceeds on schedule.
- **Risk Manager** (risk-management): Current drawdown -0.01. risk_scale=1.0. DCA tranche $18,700 well within sleeve caps. Returned: verdict=APPROVE, kill_switch=false.
- **Weekly-note desk** (tradfi-portfolio-manager): Monday + monthly cadence combined. Monthly performance attribution produced. DCA ticket delegated. Returned: DCA ticket confirmed, monthly attribution below.
</desk>

<regime>
Exposure multiplier: 1.0x (score 0.65 >= 0.5 -> full target exposure). S&P 5860, 5.8% above 200d MA 5540. Drawdown from 52w high: -0.68%. Risk-on confirmed, stable. No flip signal.
</regime>

<research>
Monthly thesis check: No thesis-change flags. Regime 0.65, near-ATH — bubble-aware posture maintained but no active threat. DCA month 5 of 15 proceeding on schedule. No new ideas. All-clear.
</research>

<signals>
S&P 5860 is 5.8% above 200d MA — all equity sleeves IN. All diversifiers IN. Full risk-on, no trend exits. DCA buys confirmed across all sleeves.
</signals>

<construction>
Monthly DCA tranche: $18,700 distributed proportionally to v3 Balanced target weights:

RSP 0.18 -> $3,366
VXUS 0.12 -> $2,244
AVUV 0.08 -> $1,496
USMV 0.07 -> $1,309
GLD 0.10 -> $1,870
DBMF 0.10 -> $1,870
TLT 0.07 -> $1,309
SCHP 0.03 -> $561
SGOV 0.22 -> $4,114
BTAL 0.03 -> $561
Total: $18,700

SGOV portion ($4,114) adds to the reserve proportionally, maintaining the 22% dry-powder allocation during DCA deployment phase.
</construction>

<risk>
Risk Manager verdict: APPROVE. risk_scale=1.0. Current drawdown: -0.01. DCA tranche $18,700 is well within any individual sleeve cap (RSP buy $3,366 << 25% sleeve cap). Kill switch: false. All orders cleared.
</risk>

<cash>
Drawdown from 52w high: -0.68%. No dip tier active. Dip reserve ($220,000) untouched — separate deployment channel from monthly DCA. Both channels run in parallel per v3 deployment schedule.
</cash>

<rebalance>
No quarterly rebalance due (is_quarter_end=false). Holdings empty — no drift to measure. DCA contributions directed proportionally to all sleeves per construction above, maintaining target weight ratios.
</rebalance>

<tax>
Holdings empty (DCA purchases this cycle establish cost basis). No harvestable positions. Tax Agent notes: track today's purchase prices as cost basis for future TLH opportunities. Regular DCA creates multiple lot dates — favorable for HIFO lot selection in future harvests. No current tax action.
</tax>

<performance>
NAV: $1,005,000. DCA month 5 of 15. Monthly DCA amount: $18,700. DCA months 1-4 deployed approximately $74,800 (4 x $18,700) prior to this cycle. Dip reserve: $220,000 intact (no dip tiers fired). Foundation: $500,000 at inception.

Fund performance: NAV $1,005,000 vs $1,000,000 start = +0.5%. S&P at 5860, near all-time highs. Fund near par — SGOV reserve earning ~4-5% yield offsets DCA deployment drag. Monthly attribution: SGOV interest accruing on $220K reserve, partial equity upside on deployed DCA tranches. No correction-driven drag.

v3 lifetime benchmark: 6.8% CAGR. Full since-inception comparison deferred until fully deployed.
</performance>

<orders>
Risk Manager verdict: APPROVE (risk_scale=1.0). Monthly DCA tranche — June 2026 (month 5 of 15). Human to place — notification-first.

MONTHLY DCA TRANCHE — $18,700 across v3 Balanced mix:

1. RSP — buy $3,366 [limit at market]
2. VXUS — buy $2,244 [limit at market]
3. AVUV — buy $1,496 [limit at market]
4. USMV — buy $1,309 [limit at market]
5. GLD — buy $1,870 [limit at market]
6. DBMF — buy $1,870 [limit at market]
7. TLT — buy $1,309 [limit at market]
8. SCHP — buy $561 [limit at market]
9. SGOV — buy $4,114 [limit at $100.00]
10. BTAL — buy $561 [limit at market]

Total: $18,700. DCA month 5 of 15 complete after execution. Dip reserve ($220,000) remains untouched in SGOV — separate from this DCA tranche.
</orders>

<bull-lag>
Bull-lag acknowledgment: S&P at 5860, near all-time highs. v3 DCA into a near-ATH market means equity purchases today may underperform a hypothetical lump-sum investor. Vanguard research: lump sum beats DCA ~2/3 of the time. v3 accepts this cost: lifetime 6.8% CAGR vs S&P 8.3%; real-ETF era 2019-2026 v3 8.6% vs S&P 16.8% / QQQ 23.3%. The DCA schedule smooths entry risk; the 22% dip reserve preserves dry powder for corrections. If the bull continues with no correction, both the DCA schedule and reserve will prove suboptimal vs lump-sum — the explicit trade-off made in exchange for left-tail protection.
</bull-lag>

<audit>
{"date":"2026-06-01","cadence":["daily","weekly","monthly"],"nav":1005000,"regime_score":0.65,"exposure_multiplier":1.0,"drawdown_fund":-0.01,"drawdown_sp_52w":-0.0068,"dip_tiers_active":[],"risk_verdict":"approve","risk_scale":1.0,"dca_tranche_deployed":18700,"dca_month":5,"dca_remaining_months":10,"reserve_remaining":220000,"rebalance_breach":false}
</audit>

</fund-ops-report>

*As of 2026-06-01. Educational analysis, not advice; you place the orders.*
